<  Back to the Polytechnique Montréal portal

Identifying biomarkers of Wharton's Jelly mesenchymal stromal cells using a dynamic metabolic model: the cell passage effect

Benoît Laflaquière, Gabrielle Leclercq, Chandarong Choey, Jingkui Chen, Sabine Peres, Caryn Ito and Mario Jolicoeur

Article (2018)

[img]
Preview
Published Version
Terms of Use: Creative Commons Attribution.
Download (1MB)
[img]
Preview
Supplemental Material
Terms of Use: Creative Commons Attribution.
Download (1MB)
Cite this document: Laflaquière, B., Leclercq, G., Choey, C., Chen, J., Peres, S., Ito, C. & Jolicoeur, M. (2018). Identifying biomarkers of Wharton's Jelly mesenchymal stromal cells using a dynamic metabolic model: the cell passage effect. Metabolites, 8(1). doi:10.3390/metabo8010018
Show abstract Hide abstract

Abstract

Because of their unique ability to modulate the immune system, mesenchymal stromal cells (MSCs) are widely studied to develop cell therapies for detrimental immune and inflammatory disorders. However, controlling the final cell phenotype and determining immunosuppressive function following cell amplification in vitro often requires prolonged cell culture assays, all of which contribute to major bottlenecks, limiting the clinical emergence of cell therapies. For instance, the multipotent Wharton's Jelly mesenchymal stem/stromal cells (WJMSC), extracted from human umbilical cord, exhibit immunosuppressive traits under pro-inflammatory conditions, in the presence of interferon-gamma (IFNgamma), and tumor necrosis factor-alpha (TNFalpha). However, WJMSCs require co-culture bioassays with immune cells, which can take days, to confirm their immunomodulatory function. Therefore, the establishment of robust cell therapies would benefit from fast and reliable characterization assays. To this end, we have explored the metabolic behaviour of WJMSCs in in vitro culture, to identify biomarkers that are specific to the cell passage effect and the loss of their immunosuppressive phenotype. We clearly show distinct metabolic behaviours comparing WJMSCs at the fourth (P4) and the late ninth (P9) passages, although both P4 and P9 cells do not exhibit significant differences in their low immunosuppressive capacity. Metabolomics data were analysed using an in silico modelling platform specifically adapted to WJMSCs. Of interest, P4 cells exhibit a glycolytic metabolism compared to late passage (P9) cells, which show a phosphorylation oxidative metabolism, while P4 cells show a doubling time of 29 h representing almost half of that for P9 cells (46 h). We also clearly show that fourth passage WJMSCs still express known immunosuppressive biomarkers, although, this behaviour shows overlapping with a senescence phenotype.

Uncontrolled Keywords

Wharton's Jelly mesenchymal stem/stromal cells (WJMSC); biomarkers; immunosuppression; metabolomics

Open Access document in PolyPublie
Subjects: 1800 Génie chimique > 1800 Génie chimique
5100 Biologie cellulaire > 5100 Biologie cellulaire
5100 Biologie cellulaire > 5106 Matrice extra-cellulaire
Department: Département de génie chimique
Research Center: Autre
Date Deposited: 09 Mar 2020 11:14
Last Modified: 10 Mar 2020 01:20
PolyPublie URL: https://publications.polymtl.ca/3564/
Document issued by the official publisher
Journal Title: Metabolites (vol. 8, no. 1)
Publisher: MDPI
Official URL: https://doi.org/10.3390/metabo8010018

Statistics

Total downloads

Downloads per month in the last year

Origin of downloads

Dimensions

Repository Staff Only